How do we look at data transparency issues when scaling AI?
Case study on AI rights and a look at recently released survey discussing where things need to change
Without GDPR, what can be done to protect patients regarding data sovereignty?
Delving into the unique and amplified challenges for AI risk assessment
How can we effectively leverage AI in our heavily regulated environment?
Current biotech funding and pipeline trends shaping early and late phase development
How market dynamics are influencing trial initiation and program design in 2025
Shifts in CRO selection and strategic approaches among emerging biotechs
Discuss methods for identifying and engaging the right patient population
Learn strategies for reducing barriers to participation
Focus on enhancing site and investigator engagement training, tools, and incentives
Building trust – communication and transparency takeaways
Includes clear, relatable examples of how AI is practically applied within healthcare and pharma, empowering executives without deep technical backgrounds
Emerging Industry trends
Macroeconomic trends
Technology trends
Funding trends
Posts navigation
